Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135648) titled 'Nicotine Pharmacokinetics and Pharmacodynamics of Two Variants of VM 1.0 Compared to Cigarettes in Adult Current Smokers' on Aug. 14.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Basic Science. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Philip Morris Products S.A.
Condition:
Nicotine
Intervention:
Other: VM16
Other: VM32
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: July 17, 2025
Target Sample Size: 16
Countries of Recruitment:
United Kingdom
To know more, visi...